361 Capital’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

361 Capital’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-36,408	Closed	-$1.29M	–	419
2018 Q1	$1.29M	Buy	+36,408	New	+$1.43M	0.32%	201

Other funds holding SYNH

THLTP

Thomas H. Lee (THL) Partners Boston, Massachusetts $205M AUM 1.84% 1-Year Est. Return

Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

361 Capital's SYNH Position: Q2 2018 in Review

361 Capital sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q2 2018, closing a stake of 36,408 shares — an estimated $1.29M sold.

361 Capital first reported a position in SYNH in Q1 2018 and held it in 1 quarter. The position peaked at $1.29M in Q1 2018. 213 funds tracked by Wall St. Rank hold SYNH as of Q2 2018.

361 Capital reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q2 2018 after selling out during the quarter.
361 Capital sold 36,408 Syneos Health, Inc. Class A Common Stock shares in Q2 2018, an estimated $1.29M.
361 Capital first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2018 and held it in 1 quarter.
361 Capital's Syneos Health, Inc. Class A Common Stock position peaked at $1.29M in Q1 2018.
213 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2018.

Based on 361 Capital's 13F filing for Q2 2018, filed 14 Aug 2018.